Moderna (MRNA), once an unknown biotech firm, quickly rose to the top of the global vaccine market during the COVID-19 ...

Moderna announced Monday that its COVID-19 vaccine booster increases antibody levels against the omicron variant within a month of getting the shot. In a lab study, the company gave 20 fully ...

Moderna said in its announcement that the couple would continue to develop an omicron-specific booster shot, which it expects to advance into clinical trials in early 2022.

Now Moderna is testing a bivalent shot that better targets omicron — it includes 32 of that variant's mutations. Studies of two booster doses are underway in the U.S. and Britain; results are ...

More than 71 million people in the U.S. have been fully vaccinated with Moderna’s COVID-19 vaccine, and more than 12 million have gotten a Moderna booster as of Nov. 16, according to CDC data.

Days after BQ.1 and BQ.1.1 surpassed BA.5 — the long-standing dominant COVID-19 subvariant — Moderna said its bivalent booster showed "robust neutralizing activity" against BQ.1.1 and had a 15 ...

Currently, Moderna's booster is administered as a 50-microgram dose. The company announcement noted that its 50-microgram booster dose increased antibody levels 37-fold and a 100-microgram booster ...

Moderna says it is in the process of developing a single-shot vaccine that could serve as a COVID-19 booster shot and a flu shot. In a press release Thursday touting its fifth annual "R&D Day ...

The US Food and Drug Administration (FDA) is keeping its cards close to the vest when it comes to the potential approval of a booster dose of Moderna's COVID-19 vaccine, now called Spikevax.

Walgreens, Walmart, Sam’s Club and Rite Aid announced they’ll have the Pfizer, Moderna or J&J COVID-19 booster vaccines for eligible patients. CVS will carry Pfizer and Moderna’s booster shot.

If COVID-19 booster shots become an annual precaution, the same way we get a flu shot every year, the next one may be formulated differently. Moderna and Pfizer working on a bivalent vaccine that ...

On Thursday, Oct. 14, 2021, U.S. health advisers said that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.